Trials / Completed
CompletedNCT04350125
PRP for the Treatment of Erectile Dysfunction (ED)
A Pilot Study Evaluating the Use of Autologous Platelet-rich Plasma (PRP) for the Treatment of Erectile Dysfunction
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 4 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- Male
- Age
- 45 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
Researchers are trying to determine the safety and efficacy of Platelet Rich Plasma (PRP) in the treatment of Erectile Dysfunction (ED).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Autologous Platelet Rich Plasma | One 4-5mL platelet rich plasma injection administered to each side of the intracavernosal space on the right and left side of the corpus cavernosum at the base of the penis, every two weeks for 6 weeks. |
Timeline
- Start date
- 2022-03-04
- Primary completion
- 2023-10-23
- Completion
- 2023-10-23
- First posted
- 2020-04-16
- Last updated
- 2023-10-27
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04350125. Inclusion in this directory is not an endorsement.